Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Operating Leases (2022 - 2025)

Historic Operating Leases for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $2.0 million.

  • Lucid Diagnostics' Operating Leases fell 2899.51% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 2899.51%. This contributed to the annual value of $2.7 million for FY2024, which is 10337.16% up from last year.
  • Lucid Diagnostics' Operating Leases amounted to $2.0 million in Q3 2025, which was down 2899.51% from $2.3 million recorded in Q2 2025.
  • Lucid Diagnostics' 5-year Operating Leases high stood at $3.0 million for Q2 2024, and its period low was $1.0 million during Q1 2024.
  • Its 4-year average for Operating Leases is $2.1 million, with a median of $2.0 million in 2025.
  • Per our database at Business Quant, Lucid Diagnostics' Operating Leases plummeted by 4469.9% in 2024 and then surged by 13795.76% in 2025.
  • Over the past 4 years, Lucid Diagnostics' Operating Leases (Quarter) stood at $2.0 million in 2022, then crashed by 34.72% to $1.3 million in 2023, then surged by 103.37% to $2.7 million in 2024, then dropped by 23.32% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $2.3 million for Q2 2025, and $2.5 million during Q1 2025.